Skip to main content

7 Result(s)

within Article Remove this filter C. Bourgier Remove this filter

and

  1. No Access

    Article

    Innovations et recherche en radiothérapie en France

    Significant advances in radiation therapy have recently been observed. Important technological advances allow for greater precision in defining target volumes and organs at risk, which will certainly impact th...

    Y. Belkacémi, F. Denis, J. -M. Hannoun-Levi, C. Bourgier, A. Toledano in Oncologie (2009)

  2. No Access

    Article

    Avancées en radiothérapie externe des cancers du sein

    In the adjuvant setting, whole breast radiotherapy is the standard of care. Quality assurance (QA) is required in all steps before the start of irradiation using a relatively standardized 3D-conformal techniqu...

    Y. Belkacémi, A. Tolédano, S. Vieillot, C. Bourgier, D. Azria in Oncologie (2010)

  3. No Access

    Article

    La génétique constitutionnelle peut-elle impacter la prise en charge d’une femme atteinte de cancer du sein aujourd’hui ?

    The concept of personalized medicine has rapidly become a major part of breast cancer care. It relies on complex biological evaluations and predictions of both the prognostic and the specific treatment sensiti...

    S. Delaloge, F. Rimareix, C. Balleyguier, A. Remenieras, A. Varga, C. Uzan… in Oncologie (2010)

  4. No Access

    Article

    Stereotactic ablative radiotherapy delivered by image-guided helical tomotherapy for extracranial oligometastases

    To investigate the outcomes and risk factors of patients treated with stereotactic ablative radiotherapy (SABR) delivered by image-guided helical tomotherapy (HT) for extracranial oligometastases.

    C. V. Sole, J. L. Lopez Guerra, R. Matute, J. Jaen… in Clinical and Translational Oncology (2013)

  5. No Access

    Article

    Brèves de l’AERIO

    F. -G. Riet, C. -H. Canova, L. Feuvret, C. Bourgier in Oncologie (2013)

  6. No Access

    Article

    A phase I, dose-escalation study of the Eg5-inhibitor EMD 534085 in patients with advanced solid tumors or lymphoma

    Background The kinesin spindle protein Eg5 is involved in mitosis, and its inhibition promotes mitotic arrest. EMD 534085, a potent, reversible Eg5 inhibitor, demonstrated significant pre...

    A. Hollebecque, E. Deutsch, C. Massard, C. Gomez-Roca… in Investigational New Drugs (2013)

  7. Article

    Radiothérapie et cancer du sein : le point sur les outils développés en recherche translationnelle

    C. Bourgier in Oncologie (2017)

    Download PDF (82 KB)